title: Inflammatory spleen monocytes can upregulate CD11c expression without converting into dendritic cells.
abstract: Monocytes can differentiate into various cell types with unique specializations depending on their environment. Under certain inflammatory conditions, monocytes upregulate expression of the dendritic cell marker CD11c together with MHC and costimulatory molecules. These phenotypic changes indicate monocyte differentiation into a specialized subset of dendritic cells (DCs), often referred to as monocyte-derived DCs or inflammatory DCs (iDCs), considered important mediators of immune responses under inflammatory conditions triggered by infection or vaccination. To characterize the relative contribution of cDCs and iDCs under conditions that induce strong immunity to coadministered Ags, we analyzed the behavior of spleen monocytes in response to anti-CD40 treatment. We found that under sterile inflammation in mice triggered by CD40 ligation, spleen monocytes can rapidly and uniformly exhibit signs of activation, including a surface phenotype typically associated with their conversion into DCs. These inflammatory monocytes remain closely related to their monocytic lineage, preserving expression of CD115, scavenging function, tissue distribution and poor capacity for Ag presentation characteristic of their monocyte precursors. In addition, 3-4 d after delivery of the inflammatory stimuli, these cells reverted to a monocyte-associated phenotype typical of the steady state. These findings indicate that, in response to anti-CD40 treatment, spleen monocytes are activated and express certain DC surface markers without acquiring functional characteristics associated with DCs.
authors.affiliation: Cancer Institute, New York University School of Medicine, New York, NY 10016, USA.
authors.forename: Scott B
authors.initials: SB
authors.lastname: Drutman
authors.forename: Julia C
authors.initials: JC
authors.lastname: Kendall
authors.forename: E Sergio
authors.initials: ES
authors.lastname: Trombetta
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000494:pharmacology; D015415:Biomarkers / Q000378:metabolism; D039521:CD11c Antigen / Q000276:immunology / Q000378:metabolism*; D019013:CD40 Antigens / Q000276:immunology / Q000378:metabolism; D002454:Cell Differentiation / Q000235:genetics / Q000276:immunology*; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D005786:Gene Expression Regulation; D007249:Inflammation / Q000235:genetics / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D009000:Monocytes / Q000166:cytology / Q000276:immunology / Q000378:metabolism*; D010641:Phenotype; D016186:Receptor, Macrophage Colony-Stimulating Factor / Q000276:immunology / Q000378:metabolism; D015398:Signal Transduction; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D015415:Biomarkers; D039521:CD11c Antigen; D019013:CD40 Antigens; D016186:Receptor, Macrophage Colony-Stimulating Factor